These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
372 related articles for article (PubMed ID: 8122286)
1. Biotechnology: an introduction to recombinant DNA technology and product availability. Evens RP; Witcher M Ther Drug Monit; 1993 Dec; 15(6):514-20. PubMed ID: 8122286 [TBL] [Abstract][Full Text] [Related]
2. Quality assurance of products manufactured by recombinant DNA technology. Introduction and elements of a philosophy. van Noordwijk J Arzneimittelforschung; 1988 Jul; 38(7):943-7. PubMed ID: 3207439 [TBL] [Abstract][Full Text] [Related]
3. Biopharmaceuticals in China. Hu X; Ma Q; Zhang S Biotechnol J; 2006 Nov; 1(11):1215-24. PubMed ID: 17089435 [TBL] [Abstract][Full Text] [Related]
4. Biotechnology and molecular diagnostics. Gulino A Forum (Genova); 1999; 9(3 Suppl 3):37-46. PubMed ID: 10607845 [TBL] [Abstract][Full Text] [Related]
5. An overview of biotechnology. Demain AL Occup Med; 1991; 6(2):157-68. PubMed ID: 2047970 [TBL] [Abstract][Full Text] [Related]
6. Manufacturing of recombinant therapeutic proteins in microbial systems. Graumann K; Premstaller A Biotechnol J; 2006 Feb; 1(2):164-86. PubMed ID: 16892246 [TBL] [Abstract][Full Text] [Related]
7. Consistency and stability of recombinant fermentations. Wiebe ME; Builder SE Dev Biol Stand; 1994; 83():45-54. PubMed ID: 7883099 [TBL] [Abstract][Full Text] [Related]
9. Production of chymosin for the dairy industry by recombinant DNA technology. Yu PL Australas Biotechnol; 1994; 4(1):19-23. PubMed ID: 7764615 [TBL] [Abstract][Full Text] [Related]
10. Production and analysis of proteins by recombinant DNA technology. Pestka S Bioprocess Technol; 1990; 7():235-65. PubMed ID: 1366823 [No Abstract] [Full Text] [Related]
11. [Science of evaluating the characteristics, quality and safety of biotechnological products: RDNA-derived products, cell culture technology-derived products, gene therapy products, cellular therapy products, and transgenic animal-derived protein products and cellular products]. Hayakawa T Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 1999; (117):1-38. PubMed ID: 10859934 [TBL] [Abstract][Full Text] [Related]
12. Recombinant protein production by large-scale transient gene expression in mammalian cells: state of the art and future perspectives. Baldi L; Hacker DL; Adam M; Wurm FM Biotechnol Lett; 2007 May; 29(5):677-84. PubMed ID: 17235486 [TBL] [Abstract][Full Text] [Related]
13. Engineering cell physiology to enhance recombinant protein production in Escherichia coli. Chou CP Appl Microbiol Biotechnol; 2007 Sep; 76(3):521-32. PubMed ID: 17571257 [TBL] [Abstract][Full Text] [Related]
17. Recombinant DNA manipulations and their interfaces with protein technology. Nagley P Dev Biol Stand; 1987; 67():171-6. PubMed ID: 3475224 [TBL] [Abstract][Full Text] [Related]
19. How a collaborative task force can assist in managing biotechnology products. MacKinnon GE Hosp Formul; 1994 Jul; 29(7):526-30, 533. PubMed ID: 10135146 [TBL] [Abstract][Full Text] [Related]